Traws Pharma, Inc. Defined Contribution Plan, Cost
Traws Pharma, Inc. (TRAW) reported Defined Contribution Plan, Cost of $276.00 thousand for the 12-month period ending 2014-12-31, per its 10-K filed 2015-03-30.
Discontinued › Expense Statement › Operating Expenses
us-gaap:DefinedContributionPlanCostRecognized · last filed 2015-03-30
- Traws Pharma, Inc. defined contribution plan, cost for fiscal 2014 was $276.00K, a 4.50% decline from fiscal 2013.
- Traws Pharma, Inc. defined contribution plan, cost for fiscal 2013 was $289.00K, a 81.76% increase from fiscal 2012.
- Traws Pharma, Inc. defined contribution plan, cost for fiscal 2012 was $159.00K, a 21.37% increase from fiscal 2011.
- Traws Pharma, Inc. defined contribution plan, cost for fiscal 2011 was $131.00K.
| Period end | Defined Contribution Plan, Cost 12 month |
|---|---|
| 2014-12-31 | $276.00K 10-K · filed 2015-03-30 |
| 2013-12-31 | $289.00K 10-K · filed 2015-03-30 |
| 2012-12-31 | $159.00K 10-K · filed 2015-03-30 |
| 2011-12-31 | $131.00K 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alzamend Neuro, Inc. (ALZN) | United States | $0.009B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| FibroBiologics, Inc. (FBLG) | United States | $0.009B | -0.27 |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| InMed Pharmaceuticals Inc. (INM) | $0.008B | -0.65 | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B |